Engineering Strategies for Oral Therapeutic Enzymes to Enhance Their Stability and Activity
- 4 September 2019
- book chapter
- Published by Springer Nature
- Vol. 1148, 151-172
Abstract
Oral application of therapeutic enzymes is a promising and non-invasive administration that improves patient compliance. However, the gastrointestinal tract poses several challenges to the oral delivery of proteins, including harsh pH conditions and digestive proteases. A promising way to stabilise enzymes during their gastrointestinal route is by modification with polymers that can provide both steric shielding and selective interaction in different digestive compartments. We give an overview of modification technologies for oral enzymes ranging from functionalisation of native proteins, to site-specific mutation and protein-polymer engineering. We specifically focus on enzymes that are active directly in the gastrointestinal lumen and not systemically absorbed. In addition, we discuss examples of microparticle and nanoparticle encapsulated enzymes for improved oral delivery. The modification of orally administered enzymes offers a broad chemical variability and may be a promising tool for enhancing their gastrointestinal stability.Keywords
This publication has 71 references indexed in Scilit:
- Consumption of gluten with gluten-degrading enzyme by celiac patients: A pilot-studyWorld Journal of Gastroenterology, 2013
- In vivo fluorescence imaging of exogenous enzyme activity in the gastrointestinal tractProceedings of the National Academy of Sciences, 2011
- PhenylketonuriaThe Lancet, 2010
- Converting an injectable protein therapeutic into an oral form: Phenylalanine ammonia lyase for phenylketonuriaMolecular Genetics and Metabolism, 2010
- Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrierProceedings of the National Academy of Sciences, 2009
- Enzymatic activity and thermal stability of PEG-α-chymotrypsin conjugatesBiotechnology Letters, 2009
- Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuriaProceedings of the National Academy of Sciences, 2008
- Protein engineering of improved prolyl endopeptidases for celiac sprue therapyProtein Engineering, Design and Selection, 2008
- Stabilization of α‐chymotrypsin upon PEGylation correlates with reduced structural dynamicsBiotechnology and Bioengineering, 2008
- Comparative Effects of Antacids, Cimetidine and Enteric Coating on the Therapeutic Response to Oral Enzymes in Severe Pancreatic InsufficiencyNew England Journal of Medicine, 1977